Epigenomic analysis sheds light on risk factors for ALS : co

In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.

Related Keywords

United States , American , Lyle Ostrow , Ernest Fraenkel , Stanislav Tsitkov , Abbvie Foundation , Bruce Edwards Foundation , National Institutes Of Health , Groverm Hermann Professor In Health Sciences , Nature Communications , Bari Lipp Foundation , Microsoft , Caterpillar Foundation , Team Gleason , Robert Packard Center , National Football League , Muscular Dystrophy Association , A Cure Foundation , Fishman Family Foundation , American Airlines , Jean Pape Adams Charitable Foundation , Drug Administration , Research At Johns Hopkins University , Chan Zuckerberg Initiative , Department Of Biological Engineering , Us National Institutes Of Health , Health Sciences , Biological Engineering , Lewis Katz School , Temple University , Johns Hopkins University , Travelers Insurance , Cure Foundation , Stay Strong , Aviators Against , Myles Turner , Gates Ventures , Bari Lipp , National Institutes , Research Fellowship Program , Drug Discovery , Amyotrophic Lateral Sclerosis Als , Epigenomics , Induced Pluripotent Stem Cells ,